Articles tagged "Liver transplantation"

2020 American Transplant Congress
Alcohol Relapse after Liver Transplant for Alcohol-Related Cirrhosis: A Longitudinal Assessment of Risk Factors for Relapse and Long-Term Survival
B. Rice, N. Mehta, J. L. Dodge, J. D. Grab, C. Sherman
University of California San Francisco, San Francisco, CA
*Purpose: Relapse to alcohol after liver transplant (LT) is common but likely underreported in patients with alcohol-related cirrhosis (AC). The aim of this study was…
2020 American Transplant Congress
Serum Cystatin C Predicts Kidney-Related Outcomes and Transplant-Free Survival in Patients with End-Stage Liver Disease and Low Body Mass Index
N. Shankar¹, M. Garcia Saenz de Sicilia², A. Duarte-Rojo³, S. K. Asrani⁴, J. F. Trotter⁴, G. B. Klintmalm⁴, B. V. Fischbach⁵, S. A. Gonzalez⁵
¹Internal Medicine, Baylor Scott & White University Medical Center, Dallas, TX, ²University of Arkansas for Medical Sciences, Little Rock, AR, ³Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Center for Liver Diseases, Pittsburgh Liver Research Center, University of Pittsburgh Medical Center, Pittsburgh, PA, ⁴Baylor Simmons Transplant Institute, Dallas, TX, ⁵Baylor Simmons Transplant Institute, Fort Worth, TX
*Purpose: Liver transplant (LT) candidates with sarcopenia are disadvantaged by creatinine-based assessment of renal function as creatinine overestimates glomerular filtration rate (GFR). Low body mass…
2020 American Transplant Congress
Atrial Fibrillation Predicts Inferior Survival in Liver Transplant Recipients of Advanced Age in a Large Multicenter U.S. Cohort
M. German¹, A. Hristov¹, A. Lee¹, F. Osman¹, A. Kwong², D. Devuni³, C. Wang⁴, J. Boike⁵, J. Jo⁵, L. VanWagner⁵, M. Serper⁶, R. Sharma⁷, E. Verna⁷, J. Shor³, A. Koteish⁸, G. Sehmbey⁹, A. Seetharam⁹, N. John², Y. Patel¹⁰, M. Kappus¹⁰, T. Couri¹¹, S. Paul¹¹, R. Salgia¹², Q. Nhu¹³, C. Frenette¹³, J. Lai⁴, A. Goel², E. Spengler¹
¹U of Wisconsin, Madison, WI, ²Stanford, Palo Alto, CA, ³U of Massachusetts, Worcester, MA, ⁴U of California, San Francisco, CA, ⁵Northwestern, Chicago, IL, ⁶U of Pennsylvania, Philadelphia, PA, ⁷Columbia, New York, NY, ⁸Florida Hospital, Orlando, FL, ⁹U of Arizona, Phoenix, AZ, ¹⁰Duke, Durham, NC, ¹¹U of Chicago, Chicago, IL, ¹²Henry Ford Hospital, Detroit, MI, ¹³Scripps, San Diego, CA
*Purpose: More liver transplants (LT) are being performed in patients >65 years (y) - a population with higher rates of cardiovascular (CV) disease. It is…
2020 American Transplant Congress
Impact and Outcomes of Primary Cytomegalovirus Infection in Seronegative Abdominal Solid Organ Transplant Recipients of Cytomegalovirus Unexposed Donors (D-/R-)
M. Jorgenson¹, M. Hillis¹, N. Friedlander¹, A. Gracon², D. Yang², G. Leverson², J. Smith², R. Redfield²
¹UWHC, Madison, WI, ²UWMF, Madison, WI
*Purpose: Primary cytomegalovirus infection (CMV) in high risk (D+/R-) abdominal solid organ transplant recipients (aSOTRs) is well described, however there is a paucity of literature…
2020 American Transplant Congress
Liver Transplantation from Donors after Circulatory Death Using “tPA”Protocol: The University of Miami Experience
R. Vianna, A. Farag, G. Selvaggi, A. Tekin, W. De Faria, M. Morsi, R. Miyashiro, T. Beduschi
University of Miami, Miami Transplant Institute, Miami, FL
*Purpose: Expansion of liver transplantation (LT) from donors after circulatory death (DCD) has been increasingly used to overcome the persistent organ shortage and long waiting…
2020 American Transplant Congress
Transplant Outcomes, Risk Factors, and Regional Variation in Selection of Morbidly Obese Liver Transplant Candidates in the US
T. Lian¹, N. Kaur², J. Emamaullee², M. Lo³, P. Ender⁴, J. Kahn⁵, L. Sher²
¹Keck School of Medicine at USC, Los Angeles, CA, ²Department of Surgery, Keck School of Medicine at USC, Los Angeles, CA, ³Department of Preventative Medicine, Keck School of Medicine at USC, Los Angeles, CA, ⁴Statistical Consulting Group, University of California Los Angeles, Los Angeles, CA, ⁵Department of Medicine, Keck School of Medicine at USC, Los Angeles, CA
*Purpose: Body Mass Index (BMI) limits for liver transplant (LT) candidacy are controversial. We evaluated waitlist and post-LT outcomes, prognostic factors, and regional patterns of…
2020 American Transplant Congress
Hepatitis C and Racial Disparity in Liver Transplant Waitlist Additions: Separate Not Equal
C. Wang¹, J. Buggs¹, E. Rogers¹, A. Kumar², N. Kemmer³
¹Transplant Surgery, Tampa General Hospital, Tampa, FL, ²Morsani College of Medicine, University of South Florida, Tampa, FL, ³Transplant Hepatology, Tampa General Hospital, Tampa, FL
*Purpose: In 2014, direct-acting antivirals (DAAs) became available as a treatment option for Hepatitis C Virus (HCV) with successful results. Since the implementation of DAAs,…
2020 American Transplant Congress
Flagging of Transplant Centers Associated with Increased Waitlist Mortality among Liver Candidates
R. L. Grant, B. A. Shelton, P. A. MacLennan, R. D. Reed, R. M. Cannon, B. J. Orandi, D. E. Eckhoff, J. E. Locke
University of Alabama at Birmingham, Birmingham, AL
*Purpose: Previous studies have demonstrated decreased transplant rates among poor performing transplant centers meeting Centers for Medicare & Medicaid Services (CMS) flagging criteria. However, no…
2020 American Transplant Congress
Factors Associated with Hepatocellular Carcinoma Understaging for Liver Transplantation, and Variation in Understaging by Transplant Center
N. Mahmud¹, M. Hoteit¹, D. Goldberg²
¹Hospital of the University of Pennsylvania, Philadelphia, PA, ²University of Miami, Miami, FL
*Purpose: Hepatocellular carcinoma (HCC) may be cured by liver transplantation (LT) in selected patients, though recurrence rates remain high. Patients who are reported as within…
2020 American Transplant Congress
Predictors of Estimated GFR and Recurrent Chronic Kidney Disease (CKD) after Simultaneous Liver and Kidney Transplantation (SLKT): Results from the US Multicenter SKLT Consortium
P. Sharma¹, Z. Sui¹, M. Zhang¹, J. Magee¹, P. Barman², Y. Patel³, K. Walters⁴, S. Biggins⁵, A. Schluger⁶, G. Cullaro⁷, R. Wong⁸, J. Lai⁸, J. Jo⁹, J. Sinha⁹, L. VanWagner⁹, E. Verna⁷
¹Michigan Medicine, Ann Arbor, MI, ²UCSD, San Diego, CA, ³Duke, Durham, NC, ⁴UCLA, LA, CA, ⁵University of Washington, Seattle, WA, ⁶Westchester Medical Center, Weschester, NY, ⁷Columbia, New York, NY, ⁸UCSF, San Francisco, CA, ⁹Northwestern, Chicago, IL
*Purpose: SLKT is a life-saving intervention for patients with decompensated cirrhosis and concomitant end stage renal disease, irreversible acute kidney injury and select inherited metabolic…